Feilding A

The Beckley Foundation, Oxford, UK.

30 papers · 2 preprints · ORCID

ArticleLSD

A randomised placebo-controlled study of the effects of lysergic acid diethylamide microdosing (15 μg) on pain perception in healthy volunteers.

Cavarra M, Hutten NRPW, Schepers J +7

Europe PMC2025
ArticleDMT

Autonomic nervous system activity correlates with peak experiences induced by DMT and predicts increases in well-being.

Bonnelle V, Feilding A, Rosas FE +3

Europe PMC2024
ArticleLSD

LSD Modulates Proteins Involved in Cell Proteostasis, Energy Metabolism and Neuroplasticity in Human Cerebral Organoids.

N Costa M, Goto-Silva L, M Nascimento J +6

Europe PMC2024
ArticleLSD

Inter-individual variability in neural response to low doses of LSD.

Hutten NRPW, Quaedflieg CWEM, Mason NL +7

Europe PMC2024
PreprintDMT

Autonomic Nervous System activity correlates with peak experiences induced by DMT and predicts increases in wellbeing

Bonnelle V, Feilding A, Rosas FE +3

Europe PMC2024
PreprintLSD

LSD Modulates Proteins Involved in Cell Proteostasis, Energy Metabolism and Neuroplasticity in Human Cerebral Organoids

Costa MN, Goto-Silva L, Nascimento JM +6

Europe PMC2024
ArticleLSD

Effects of External Stimulation on Psychedelic State Neurodynamics.

Mediano PAM, Rosas FE, Timmermann C +10

Europe PMC2024
ArticlePsilocybin

Potential analgesic effects of psychedelics on select chronic pain conditions: A survey study.

Cavarra M, Mason NL, Kuypers KPC +5

Europe PMC2024
ArticlePsychedelics

Cortical Correlates of Psychedelic-Induced Shaking Behavior Revealed by Voltage Imaging.

Buchborn T, Lyons T, Song C +2

Europe PMC2023
ArticleLSD

LSD and language: Decreased structural connectivity, increased semantic similarity, changed vocabulary in healthy individuals.

Wießner I, Falchi M, Daldegan-Bueno D +7

Europe PMC2023
ArticlePsychedelics

Analgesic potential of macrodoses and microdoses of classical psychedelics in chronic pain sufferers: a population survey.

Bonnelle V, Smith WJ, Mason NL +5

Europe PMC2022
ArticleLSD

Nootropic effects of LSD: Behavioral, molecular and computational evidence.

Ornelas IM, Cini FA, Wießner I +16

Europe PMC2022
ArticleLSD

LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility.

Wießner I, Olivieri R, Falchi M +6

Europe PMC2022
ArticleLSD

LSD and creativity: Increased novelty and symbolic thinking, decreased utility and convergent thinking.

Wießner I, Falchi M, Maia LO +10

Europe PMC2022
ArticleLSD

Low-dose LSD and the stream of thought: Increased Discontinuity of Mind, Deep Thoughts and abstract flow.

Wießner I, Falchi M, Palhano-Fontes F +6

Europe PMC2022
ArticleLSD

LSD, madness and healing: Mystical experiences as possible link between psychosis model and therapy model.

Wießner I, Falchi M, Palhano-Fontes F +3

Europe PMC2023
ArticleAyahuasca

The Shipibo Ceremonial Use of Ayahuasca to Promote Well-Being: An Observational Study.

Gonzalez D, Cantillo J, Perez I +6

Europe PMC2021
ArticlePsilocybin

Spontaneous and deliberate creative cognition during and after psilocybin exposure.

Mason NL, Kuypers KPC, Reckweg JT +7

Europe PMC2021
ArticlePsychedelics

Self-blinding citizen science to explore psychedelic microdosing.

Szigeti B, Kartner L, Blemings A +5

Europe PMC2021
ArticleLSD

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants.

Holze F, Liechti ME, Hutten NRPW +7

Europe PMC2021
ArticleLSD

Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study.

Hutten NRPW, Mason NL, Dolder PC +6

Europe PMC2020
ArticleLSD

Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers.

Hutten NRPW, Mason NL, Dolder PC +8

Europe PMC2021
ArticleLSD

A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers.

Ramaekers JG, Hutten N, Mason NL +6

Europe PMC2021
ArticlePsilocybin

Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin.

Mason NL, Kuypers KPC, Müller F +8

Europe PMC2020
ArticlePsychedelics

The serotonin 2A receptor agonist 25CN-NBOH increases murine heart rate and neck-arterial blood flow in a temperature-dependent manner.

Buchborn T, Lyons T, Song C +2

Europe PMC2020
ArticleAyahuasca

Four Weekly Ayahuasca Sessions Lead to Increases in "Acceptance" Capacities: A Comparison Study With a Standard 8-Week Mindfulness Training Program.

Soler J, Elices M, Dominguez-Clavé E +5

Europe PMC2018
ArticlePsilocybin

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.

Carhart-Harris RL, Bolstridge M, Day CMJ +13

Europe PMC2018
ArticleAyahuasca

Assessing the Psychedelic "After-Glow" in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities.

Sampedro F, de la Fuente Revenga M, Valle M +14

Europe PMC2017
ArticleAyahuasca

The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro.

Morales-García JA, de la Fuente Revenga M, Alonso-Gil S +4

Europe PMC2017
ArticleLSD

LSD-induced entropic brain activity predicts subsequent personality change.

Lebedev AV, Kaelen M, Lövdén M +4

Europe PMC2016
ArticleLSD

LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion.

Roseman L, Sereno MI, Leech R +6

Europe PMC2016
ArticleLSD

Neural correlates of the LSD experience revealed by multimodal neuroimaging.

Carhart-Harris RL, Muthukumaraswamy S, Roseman L +23

Europe PMC2016